DanCann Pharma AS (FRA:DAN) COGS-to-Revenue : 0.86 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is DanCann Pharma AS COGS-to-Revenue?

DanCann Pharma AS's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.21 Mil. Its Revenue for the three months ended in Sep. 2024 was €0.25 Mil.

DanCann Pharma AS's COGS to Revenue for the three months ended in Sep. 2024 was 0.86.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DanCann Pharma AS's Gross Margin % for the three months ended in Sep. 2024 was 14.06%.

DanCann Pharma AS COGS-to-Revenue Historical Data

The historical data trend for DanCann Pharma AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DanCann Pharma AS COGS-to-Revenue Chart

DanCann Pharma AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

8.40

1.99

1.54

DanCann Pharma AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															1.33	1.92	1.99	0.65	0.86

DanCann Pharma AS COGS-to-Revenue Calculation

DanCann Pharma AS's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.314	/	0.852
	=	1.54

DanCann Pharma AS's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.214	/	0.249
	=	0.86

DanCann Pharma AS (FRA:DAN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DanCann Pharma AS's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.214 / 0.249
	=	14.06 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

DanCann Pharma AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DanCann Pharma AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DanCann Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (FRA:DAN) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

DANCAN:Sweden

Address

Rugvaenget 5, Ansager, DNK, DK-6823

Website

https://www.dancann.com

DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.